|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Chloroquine remains the first-line therapy for uncomplicated malaria in Indonesia. Among a series of trials of chloroquine for malaria on this archipelago conducted since 1990, we now report the highest risk of therapeutic failure yet observed. A clinical trial of standard chloroquine therapy for uncomplicated malaria at Arso PIR V in northeastern Indonesian Papua was conducted during 1995. We enrolled 104 non-immune subjects infected with Plasmodium falciparum (n = 55), P. vivax (n = 29), or P. falciparum plus P. vivax (n = 20) and administered supervised standard chloroquine therapy (10 + 10 + 5 mg/kg at 24-hour intervals). The 28-day cumulative incidence of therapeutic failure was 95% for P. falciparum, 84% for P. vivax, and 100% for mixed infections. Only one subject each for P. falciparum and P. vivax remained free of parasites at day 28. All recurrent parasitemias occurred with whole blood levels of chloroquine plus desethylchloroquine exceeding 100 ng/ml. These findings document almost complete failure of chloroquine against P. falciparum or P. vivax near the northeastern coast of Indonesian Papua.
Received August 14, 2002. Accepted for publication December 23, 2002.
Acknowledgments: We thank the officials of the Ministry of Health, Government of Indonesia, especially Dr. Sumaryati Aryoso in Jakarta; Dr. Slamet Harjosuwarno and Dr. Lana of the Provincial Health Service in Jayapura, Papua; Patriot, Mantri Hendrik, and Sukimin; Sofyan Sauri (the Department of Transmigration officer in charge of Arso Pir V) and his assistant, Supriyanto, for their advice and assistance.
Financial support: This work was supported by the U.S. Department of Defense Global Emerging Infections Surveillance Program.
Disclaimer: The views of the authors expressed herein are their own and do not purport to reflect those of the U.S. Navy or the Department of Defense.
Authors addresses: Iwa W. Sumawinata, Budhi Leksana, Awalludin Sutamihardja, Purnomo, and J. Kevin Baird, U.S. Naval Medical Research Unit No. 2, American Embassy, Jakarta, Indonesia, FPO AP 96520-8132, Fax: 62-21-424-4507, E-mail: bairdjk{at}namru2.med.navy.mil. Bernadeta and Budi Subianto, Provincial Health Service, Abepura, Papua, Indonesia. Sekartuti, Infectious Disease Research Center, Ministry of Health, Jakarta, Indonesia. David J. Fryauff, Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910-7500.
This article has been cited by other articles:
![]() |
S. W. Lee, M. Lee, D. D. Lee, C. Kim, Y.-J. Kim, J.-Y. Kim, M. D. Green, T. A. Klein, H. C. Kim, H. Nettey, et al. Biological Resistance of Hydroxychloroquine for Plasmodium vivax Malaria in the Republic of Korea Am J Trop Med Hyg, October 1, 2009; 81(4): 600 - 604. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Sutanto, S. Suprijanto, Nurhayati, P. Manoempil, and J. K. Baird Resistance to Chloroquine by Plasmodium vivax at Alor in the Lesser Sundas Archipelago in Eastern Indonesia Am J Trop Med Hyg, August 1, 2009; 81(2): 338 - 342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Baird Resistance to Therapies for Infection by Plasmodium vivax Clin. Microbiol. Rev., July 1, 2009; 22(3): 508 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chotivanich, J. Sattabongkot, Y. K. Choi, J. S. Park, J. Sritabal, C. S. Lim, R. Udomsangpetch, N. J. White, and W. J. Lee Antimalarial Drug Susceptibility of Plasmodium vivax in the Republic of Korea Am J Trop Med Hyg, June 1, 2009; 80(6): 902 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Hasugian, E. Tjitra, A. Ratcliff, H. Siswantoro, E. Kenangalem, R. M. Wuwung, H. L. E. Purba, K. A. Piera, F. Chalfien, J. Marfurt, et al. In Vivo and In Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium vivax Antimicrob. Agents Chemother., March 1, 2009; 53(3): 1094 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Barnadas, A. Ratsimbasoa, M. Tichit, C. Bouchier, M. Jahevitra, S. Picot, and D. Menard Plasmodium vivax Resistance to Chloroquine in Madagascar: Clinical Efficacy and Polymorphisms in pvmdr1 and pvcrt-o Genes Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4233 - 4240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Russell, F. Chalfein, B. Prasetyorini, E. Kenangalem, K. Piera, R. Suwanarusk, A. Brockman, P. Prayoga, P. Sugiarto, Q. Cheng, et al. Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivax Antimicrob. Agents Chemother., March 1, 2008; 52(3): 1040 - 1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Price, E. Tjitra, C. A. Guerra, S. Yeung, N. J. White, and N. M. Anstey Vivax Malaria: Neglected and Not Benign Am J Trop Med Hyg, December 1, 2007; 77(6_Suppl): 79 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Griffith, L. S. Lewis, S. Mali, and M. E. Parise Treatment of Malaria in the United States: A Systematic Review JAMA, May 23, 2007; 297(20): 2264 - 2277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Baird Effectiveness of Antimalarial Drugs N. Engl. J. Med., April 14, 2005; 352(15): 1565 - 1577. [Full Text] [PDF] |
||||
![]() |
M. D. Hastings, J. D. Maguire, M. J. Bangs, P. A. Zimmerman, J. C. Reeder, J. K. Baird, and C. H. Sibley Novel Plasmodium vivax dhfr Alleles from the Indonesian Archipelago and Papua New Guinea: Association with Pyrimethamine Resistance Determined by a Saccharomyces cerevisiae Expression System Antimicrob. Agents Chemother., February 1, 2005; 49(2): 733 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. SYAFRUDDIN, P. B. S. ASIH, G. J. CASEY, J. MAGUIRE, J. K. BAIRD, H. S. NAGESHA, A. F. COWMAN, and J. C. REEDER MOLECULAR EPIDEMIOLOGY OF PLASMODIUM FALCIPARUM RESISTANCE TO ANTIMALARIAL DRUGS IN INDONESIA Am J Trop Med Hyg, February 1, 2005; 72(2): 174 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. HUAMAN, K. YOSHINAGA, A. SURYANATHA, N. SUARSANA, and H. KANBARA SHORT REPORT: POLYMORPHISMS IN THE CHLOROQUINE RESISTANCE TRANSPORTER GENE IN PLASMODIUM FALCIPARUM ISOLATES FROM LOMBOK, INDONESIA Am J Trop Med Hyg, July 1, 2004; 71(1): 40 - 42. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |